NeoMedLight is a pioneering brand that specializes in developing innovative medical devices for phototherapy. They utilize a unique technology that allows for the emission of light through woven optic fibers. With a focus on improving patient care, NeoMedLight offers a range of products and services to meet various medical needs.

Their flagship device, Bilicocoon, is a phototherapy device specifically designed for the treatment of neonatal jaundice. This device has gained recognition and is currently commercialized in 30 countries worldwide. Additionally, NeoMedLight recently launched CareMin650™ in March 2020.

CareMin650™ is a cutting-edge medical device with CE marking, offering precise and hassle-free red-led photobiomodulation for severe cancer treatment complications such as Mucositis and dermatitis. The team at NeoMedLight is driven by a passion for innovation and patient well-being. Led by Co-founders and Presidents Cédric Brochier and Pierre Saint Girons, NeoMedLight benefits from their collective expertise in medical device development and international business.

To stay updated with their latest news and developments, you can sign up for their newsletter. NeoMedLight is committed to providing top-quality medical devices and advancing the field of phototherapy for better patient outcomes